Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
27.04
+1.03 (3.96%)
Sep 30, 2026, 3:00 PM CST
Mabwell (Shanghai) Bioscience Employees
Mabwell (Shanghai) Bioscience had 1,356 employees as of June 30, 2026. The number of employees increased by 31 or 2.34% since the number was reported on December 31, 2025.
Employees
1,356
Change
31
Growth
2.34%
Revenue / Employee
644.54K CNY
Profits / Employee
-693.01K CNY
Market Cap
11.61B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,356 | 31 | 2.34% |
| Dec 31, 2025 | 1,325 | -91 | -6.43% |
| Dec 31, 2024 | 1,416 | -75 | -5.03% |
| Dec 31, 2023 | 1,491 | 439 | 41.73% |
| Dec 31, 2022 | 1,052 | 365 | 53.13% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,462 |
| Tibet Cheezheng Tibetan Medicine | 3,203 |
| Jinyu Bio-technology | 1,881 |
| Jiangxi Fushine Pharmaceutical | 1,663 |
| Inner Mongolia Furui Medical Science | 946 |
| Hualan Biological Vaccine | 708 |
| Novoprotein Scientific | 696 |
| Staidson (Beijing) BioPharmaceuticals | 491 |